Table of Content

1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16

2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 24
2.2 Major Growth Drivers 26
2.3 Market Restraints and Challenges 32
2.4 Emerging Opportunities and Market Trends 35
2.5 Porter’s Fiver Forces Analysis 39

3 Segmentation of North America Market by Component 43
3.1 Market Overview by Component 43
3.2 3D Bioprinters 45
3.3 Bioinks 48

4 Segmentation of North America Market by Material 50
4.1 Market Overview by Material 50
4.2 Living Cells 52
4.3 Hydrogels 53
4.4 Extracellular Matrices 54
4.5 Other Material Types 55

5 Segmentation of North America Market by Technology 56
5.1 Market Overview by Technology 56
5.2 Inkjet 3D Bioprinting 58
5.3 Laser-assisted Bioprinting 59
5.4 Magnetic 3D Bioprinting 60
5.5 Microextrusion Bioprinting 61
5.6 Other Technologies 62

6 Segmentation of North America Market by Application 63
6.1 Market Overview by Application 63
6.2 Research Application 65
6.2.1 Drug Research 66
6.2.2 Regenerative Medicine 67
6.2.3 3D Cell Culture 68
6.3 Clinical Application 69
6.3.1 Skin 70
6.3.2 Bone and Cartilage 71
6.3.3 Blood Vessels 72
6.3.4 Other Clinical Applications 73

7 Segmentation of North America Market by End User 74
7.1 Market Overview by End User 74
7.2 Research Organization & Academic Institutes 76
7.3 Biopharmaceutical Companies 77
7.4 Hospitals 78
7.5 Other End Users 79

8 North America Market 2021-2031 by Country 80
8.1 Overview of North America Market 80
8.2 U.S. 83
8.3 Canada 86
8.4 Mexico 88

9 Competitive Landscape 90
9.1 Overview of Key Vendors 90
9.2 New Product Launch, Partnership, Investment, and M&A 93
9.3 Company Profiles 94
3D Bio-printing Solutions 94
3D Systems Inc. 96
3DBio Therapeutics 97
Advanced Solutions Life Sciences LLC (ASI) 98
Aspect Biosystems Ltd. 99
Bico Group AB 100
Brinter 101
Cellink AB 102
CollPlant Biotechnologies Ltd. 103
Cyfuse Biomedical K. K. 104
Digilab Inc. 105
EnvisionTEC GmbH (Desktop Metal Inc.) 106
Foldink Life Science Technologies 107
GeSiM – Gesellschaft f?r Silizium-Mikrosysteme mbH 108
Inventia Life Science Pty Ltd. 109
Nano3D Biosciences Inc. 110
Organovo Holdings Inc 111
Pandorum Technologies Pvt. Ltd. 112
Poietis 113
Precise Bio 114
Prellis Biologics 115
Regemat 3D S.L. 116
RegenHU SA 117
Regenovo Biotechnology Co. Ltd. (Part of Shining 3D Tech Co., Ltd.) 118
ROKIT Healthcare, INC. 119
Stratasys Ltd. 120
TeVido BioDevices, Inc. 121
Vivax Bio, LLC 122
RELATED REPORTS 123



List of Figures

List of Figures:

Figure 1. Research Method Flow Chart 11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 16
Figure 4. North America 3D Bioprinting Market, 2021-2031, $ mn 19
Figure 5. Impact of COVID-19 on Business 24
Figure 6. Primary Drivers and Impact Factors of North America 3D Bioprinting Market 26
Figure 7. Total North America Regenerative Medicine Financing, 2018-2021 1H, $ mn 29
Figure 8. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 30
Figure 9. World Population 65 and Over, % of Total Population, 1950-2060 30
Figure 10. Primary Restraints and Impact Factors of North America 3D Bioprinting Market 32
Figure 11. Investment Opportunity Analysis 36
Figure 12. Porter’s Fiver Forces Analysis of North America 3D Bioprinting Market 39
Figure 13. Breakdown of North America 3D Bioprinting Market by Component, 2021-2031, % of Revenue 44
Figure 14. North America Addressable Market Cap in 2022-2031 by Component, Value ($ mn) and Share (%) 44
Figure 15. North America 3D Bioprinting Market by Component: 3D Bioprinters, 2021-2031, $ mn 45
Figure 16. North America 3D Bioprinting Market by Component: Bioinks, 2021-2031, $ mn 48
Figure 17. Breakdown of North America 3D Bioprinting Market by Material, 2021-2031, % of Sales Revenue 51
Figure 18. North America Addressable Market Cap in 2022-2031 by Material, Value ($ mn) and Share (%) 51
Figure 19. North America 3D Bioprinting Market by Material: Living Cells, 2021-2031, $ mn 52
Figure 20. North America 3D Bioprinting Market by Material: Hydrogels, 2021-2031, $ mn 53
Figure 21. North America 3D Bioprinting Market by Material: Extracellular Matrices, 2021-2031, $ mn 54
Figure 22. North America 3D Bioprinting Market by Material: Other Material Types, 2021-2031, $ mn 55
Figure 23. Breakdown of North America 3D Bioprinting Market by Technology, 2021-2031, % of Sales Revenue 57
Figure 24. North America Addressable Market Cap in 2022-2031 by Technology, Value ($ mn) and Share (%) 57
Figure 25. North America 3D Bioprinting Market by Technology: Inkjet 3D Bioprinting, 2021-2031, $ mn 58
Figure 26. North America 3D Bioprinting Market by Technology: Laser-assisted Bioprinting, 2021-2031, $ mn 59
Figure 27. North America 3D Bioprinting Market by Technology: Magnetic 3D Bioprinting, 2021-2031, $ mn 60
Figure 28. North America 3D Bioprinting Market by Technology: Microextrusion Bioprinting, 2021-2031, $ mn 61
Figure 29. North America 3D Bioprinting Market by Technology: Other Technologies, 2021-2031, $ mn 62
Figure 30. Breakdown of North America 3D Bioprinting Market by Application, 2021-2031, % of Revenue 64
Figure 31. North America Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%) 64
Figure 32. North America 3D Bioprinting Market by Application: Research Application, 2021-2031, $ mn 65
Figure 33. North America 3D Bioprinting Market by Research Application: Drug Research, 2021-2031, $ mn 66
Figure 34. North America 3D Bioprinting Market by Research Application: Regenerative Medicine, 2021-2031, $ mn 67
Figure 35. North America 3D Bioprinting Market by Research Application: 3D Cell Culture, 2021-2031, $ mn 68
Figure 36. North America 3D Bioprinting Market by Application: Clinical Application, 2021-2031, $ mn 69
Figure 37. North America 3D Bioprinting Market by Clinical Application: Skin, 2021-2031, $ mn 70
Figure 38. North America 3D Bioprinting Market by Clinical Application: Bone and Cartilage, 2021-2031, $ mn 71
Figure 39. North America 3D Bioprinting Market by Clinical Application: Blood Vessels, 2021-2031, $ mn 72
Figure 40. North America 3D Bioprinting Market by Clinical Application: Other Clinical Applications, 2021-2031, $ mn 73
Figure 41. Breakdown of North America 3D Bioprinting Market by End User, 2021-2031, % of Revenue 75
Figure 42. North America Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 75
Figure 43. North America 3D Bioprinting Market by End User: Research Organization & Academic Institutes, 2021-2031, $ mn 76
Figure 44. North America 3D Bioprinting Market by End User: Biopharmaceutical Companies, 2021-2031, $ mn 77
Figure 45. North America 3D Bioprinting Market by End User: Hospitals, 2021-2031, $ mn 78
Figure 46. North America 3D Bioprinting Market by End User: Other End Users, 2021-2031, $ mn 79
Figure 47. Breakdown of North America 3D Bioprinting Market by Country, 2021 and 2031, % of Revenue 81
Figure 48. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 82
Figure 49. U.S. 3D Bioprinting Market, 2021-2031, $ mn 84
Figure 50. Canada 3D Bioprinting Market, 2021-2031, $ mn 86
Figure 51. 3D Bioprinting Market in Mexico, 2021-2031, $ mn 88
Figure 52. Growth Stage of North America 3D Bioprinting Industry over the Forecast Period 90

List of Tables

List of Tables:

Table 1. Snapshot of North America 3D Bioprinting Market in Balanced Perspective, 2021-2031 17
Table 2. World Economic Outlook, 2021-2031 21
Table 3. World Economic Outlook, 2021-2023 22
Table 4. World Health Spending by Region, $ bn, 2013-2020 31
Table 5. Main Product Trends and Market Opportunities in North America 3D Bioprinting Market 35
Table 6. North America 3D Bioprinting Market by Component, 2021-2031, $ mn 43
Table 7. Main Vendors and 3D Bioprinters on Market 46
Table 8. Comparison of Types of Bioprinters 47
Table 9. North America 3D Bioprinting Market: Bioinks by Type, 2021-2031, $ mn 48
Table 10. Main Vendors and 3D Bioinks on Market 49
Table 11. North America 3D Bioprinting Market by Material, 2021-2031, $ mn 50
Table 12. North America 3D Bioprinting Market by Technology, 2021-2031, $ mn 56
Table 13. North America 3D Bioprinting Market by Application, 2021-2031, $ mn 63
Table 14. North America 3D Bioprinting Market: Research Application by Type, 2021-2031, $ mn 65
Table 15. North America 3D Bioprinting Market: Clinical Application by Type, 2021-2031, $ mn 69
Table 16. North America 3D Bioprinting Market by End User, 2021-2031, $ mn 74
Table 17. North America 3D Bioprinting Market by Country, 2021-2031, $ mn 81
Table 18. U.S. 3D Bioprinting Market by Component, 2021-2031, $ mn 85
Table 19. U.S. 3D Bioprinting Market by Material, 2021-2031, $ mn 85
Table 20. U.S. 3D Bioprinting Market by Application, 2021-2031, $ mn 85
Table 21. Canada 3D Bioprinting Market by Component, 2021-2031, $ mn 87
Table 22. Canada 3D Bioprinting Market by Material, 2021-2031, $ mn 87
Table 23. Canada 3D Bioprinting Market by Application, 2021-2031, $ mn 87
Table 24. Mexico 3D Bioprinting Market by Component, 2021-2031, $ mn 89
Table 25. Mexico 3D Bioprinting Market by Material, 2021-2031, $ mn 89
Table 26. Mexico 3D Bioprinting Market by Application, 2021-2031, $ mn 89
Table 27. 3D Bio-printing Solutions: Company Snapshot 94
Table 28. 3D Bio-printing Solutions: Business Segmentation 95
Table 29. 3D Bio-printing Solutions: Product Portfolio 95